COST EFFECTIVENESS OF ICATIBANT FOR HEREDITARY ANGIOEDEMA IN BRAZIL: CHALLENGES IN THE ECONOMIC EVALUATION OF ORPHAN DRUGS

Authors :: Carlos Alberto da Silva Magliano
Bernardo Rangel Tura
Kátia Marie Simões e Senna
M.G. Costa
Marisa Santos
Source :: Value in Health. 19:A248
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: medicine.medical_specialty
business.industry
Cost effectiveness
Health Policy
Public Health, Environmental and Occupational Health
medicine.disease
Orphan drug
chemistry.chemical_compound
chemistry
Icatibant
Hereditary angioedema
Economic evaluation
Medicine
business
Intensive care medicine

Full Text Access

Tools